Predictive Oncology (POAI) Competitors $1.02 -0.16 (-13.14%) As of 12:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock POAI vs. TMDIF, CTCX, ECOR, RBOT, POCI, CLGN, COCH, VVOS, STRR, and PETVShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include Titan Medical (TMDIF), Carmell (CTCX), electroCore (ECOR), Vicarious Surgical (RBOT), Precision Optics (POCI), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Vivos Therapeutics (VVOS), Star Equity (STRR), and PetVivo (PETV). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. Its Competitors Titan Medical Carmell electroCore Vicarious Surgical Precision Optics CollPlant Biotechnologies Envoy Medical Vivos Therapeutics Star Equity PetVivo Titan Medical (NASDAQ:TMDIF) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk. Do analysts prefer TMDIF or POAI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, TMDIF or POAI? Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Does the media prefer TMDIF or POAI? In the previous week, Predictive Oncology had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for Predictive Oncology and 0 mentions for Titan Medical. Predictive Oncology's average media sentiment score of 0.98 beat Titan Medical's score of 0.00 indicating that Predictive Oncology is being referred to more favorably in the news media. Company Overall Sentiment Titan Medical Neutral Predictive Oncology Positive Which has stronger earnings and valuation, TMDIF or POAI? Titan Medical has higher revenue and earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Medical$17.63M2.46$6.95M$0.057.60Predictive Oncology$1.62M6.89-$12.66M-$3.05-0.34 Do insiders & institutionals have more ownership in TMDIF or POAI? 0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 3.4% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is TMDIF or POAI more profitable? Titan Medical has a net margin of 0.00% compared to Predictive Oncology's net margin of -587.31%. Titan Medical's return on equity of -82.31% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Titan MedicalN/A -82.31% -51.47% Predictive Oncology -587.31%-722.01%-167.23% SummaryTitan Medical and Predictive Oncology tied by winning 7 of the 14 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologyMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.16M$2.11B$5.65B$10.32BDividend YieldN/AN/A5.68%4.61%P/E Ratio-0.3435.7875.6626.31Price / Sales6.8910.78521.00169.30Price / CashN/A59.5337.5661.52Price / Book-34.1710.8512.996.34Net Income-$12.66M-$63.46M$3.29B$270.94M7 Day Performance3.83%0.48%-0.03%0.29%1 Month Performance11.58%-1.02%4.13%6.89%1 Year Performance29.75%33.80%69.08%29.31% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology0.571 of 5 stars$1.03-13.1%N/A+48.3%$11.16M$1.62M-0.3430News CoverageTMDIFTitan MedicalN/A$0.36flatN/A+780.0%$41.28M$17.63M-0.2950CTCXCarmellN/A$1.92-17.4%N/A+177.8%$40.05M$32.84K0.0014ECORelectroCore2.3234 of 5 stars$4.83+1.9%$25.50+428.0%-23.4%$35.95M$27.70M-2.9850RBOTVicarious Surgical1.7274 of 5 stars$5.85+0.5%$7.00+19.7%+8.3%$34.52MN/A-0.58210POCIPrecision Optics0.201 of 5 stars$4.39-0.5%N/A-25.0%$33.77M$19.10M-4.9380News CoveragePositive NewsUpcoming EarningsCLGNCollPlant Biotechnologies2.2402 of 5 stars$2.63+0.4%$11.50+337.3%-47.6%$33.32M$2.40M-2.3370COCHEnvoy Medical2.0345 of 5 stars$1.33+3.1%$9.25+595.5%-76.5%$27.76M$222K-0.9334News CoverageVVOSVivos Therapeutics2.5204 of 5 stars$3.38-2.6%$4.92+45.5%+14.5%$26.04M$14.39M-2.01160STRRStar Equity1.2815 of 5 stars$9.81+4.7%$5.00-49.0%+181.8%$25.82M$140.06M-7.551,300News CoverageAnalyst RevisionPETVPetVivoN/A$0.95+5.9%N/A+106.1%$25.11M$1.05M-2.1220Gap Down Related Companies and Tools Related Companies Titan Medical Competitors Carmell Competitors electroCore Competitors Vicarious Surgical Competitors Precision Optics Competitors CollPlant Biotechnologies Competitors Envoy Medical Competitors Vivos Therapeutics Competitors Star Equity Competitors PetVivo Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POAI) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free POAI Stock Alerts